Form 4: Biofrontera CEO Reports Stock Transaction
Insider Transaction (Form 4)
Hermann Luebbert, CEO & Chairman and a Director of Biofrontera Inc., reported multiple transactions in common stock on July 28, 2026.
Summary
- Option exercise/conversion: acquired 62,500 Common Stock on July 28, 2026; holds 352,711 after (Direct).
- Option exercise/conversion: disposed of 62,500 Restricted Stock Units on July 28, 2026; holds 62,500 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Hermann Luebbert — Director, Officer (CEO & Chairman)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Option exercise/conversion | Common Stock | 62,500 | — | — | 352,711 |
| 2026-07-28 | Option exercise/conversion | Restricted Stock Units | 62,500 | — | — | 62,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Option exercise/conversion (62,500 shares) |
| 2026-07-28 | Option exercise/conversion (62,500 shares) |
Keywords
insider transaction, Form 4, BFRI, Biofrontera Inc., neutral, Hermann Luebbert
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.